Breast cancer stem cells: A review of their characteristics and the agents that affect them
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …
development, evolution and heterogeneity, has overridden the previous model of a tumor …
Breast cancer stem cells: A review of their characteristics and the agents that affect them
NL Shan, Y Shin, G Yang… - Molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …
development, evolution and heterogeneity, has overridden the previous model of a tumor …
Breast cancer stem cells: A review of their characteristics and the agents that affect them.
NL Shan, Y Shin, G Yang, P Furmanski… - Molecular …, 2021 - europepmc.org
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …
development, evolution and heterogeneity, has overridden the previous model of a tumor …
Breast cancer stem cells: A review of their characteristics and the agents that affect them
NL Shan, Y Shin, G Yang… - Molecular …, 2021 - researchwithrutgers.com
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …
development, evolution and heterogeneity, has overridden the previous model of a tumor …
[HTML][HTML] Breast Cancer Stem Cells: A Review of Their Characteristics and The Agents That Affect Them
NL Shan, Y Shin, G Yang, P Furmanski… - Molecular …, 2021 - ncbi.nlm.nih.gov
The evolving concept that cancer stem cells (CSCs) are the driving element in cancer
development, evolution and heterogeneity, has overridden the previous model of a tumor …
development, evolution and heterogeneity, has overridden the previous model of a tumor …